SCHEMBL29447186

SCHEMBL29447186

CCCC(C(=O)O)C1=c2ccc3c4c(ccc3c2C=C1)=CC=CC4

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15903546 0.75
SCHEMBL29564692 0.73
SCHEMBL15903796 0.72
SCHEMBL9940809 0.69 PRKDC (0.32)
SCHEMBL19972847 0.65 MEN1 (0.31)
SCHEMBL19972849 0.64 KMT2A (0.34)
SCHEMBL30813040 0.62
SCHEMBL9941388 0.61 KDM4E (0.30)
SCHEMBL9941447 0.61 CCR1 (0.34)
SCHEMBL15526804 0.60

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4171600-A1 PHARMACEUTICAL COMPOSITION COMPRISING A COMBINATION OF A GUANYLATE CYCLASE C (GUCY2C) AGONIST AND A SHORT-CHAIN FATTY ACID OR PRODRUG THEREOF OCVIRK, Sören (DE) 2023-05-03 EP claimed
EP-4171600-A1 PHARMACEUTICAL COMPOSITION COMPRISING A COMBINATION OF A GUANYLATE CYCLASE C (GUCY2C) AGONIST AND A SHORT-CHAIN FATTY ACID OR PRODRUG THEREOF OCVIRK, Sören (DE) 2023-05-03 EP disclosed
EP-4121437-A1 PRODRUGS OF 4'-C-SUBSTITUTED-2-HALO-2'-DEOXYADENOSINE NUCLEOSIDES AND METHODS OF MAKING AND USING THE SAME GILEAD SCIENCES, INC. (US) 2023-01-25 EP disclosed
EP-3947712-A1 INTESTINAL BIOMARKERS FOR GUT HEALTH IN DOMESTICATED BIRDS DuPont Nutrition Biosciences ApS (DK) 2022-02-09 EP disclosed